Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-556
Closed -$25K – 551
2025
Q3
$25K Buy
556
+15
+3% +$659 0.01% 453
2025
Q2
$23.5K Buy
541
+4
+0.7% +$178 0.01% 446
2025
Q1
$24.7K Sell
537
-107
-17% -$4.47K 0.01% 403
2024
Q4
$24.2K Buy
644
+7
+1% +$272 0.01% 531
2024
Q3
$25.8K Buy
637
+6
+1% +$226 0.01% 503
2024
Q2
$21.8K Buy
631
+7
+1% +$258 0.01% 581
2024
Q1
$23.5K Buy
+624
New +$22.3K 0.01% 534

Other funds holding EXC

Rise Advisors's EXC Position: Q4 2025 in Review

Rise Advisors sold out of Exelon (EXC) in Q4 2025, closing a stake of 556 shares — an estimated $25K sold.

Rise Advisors first reported a position in EXC in Q1 2024 and held it in 7 quarters. The position peaked at $25.8K in Q3 2024. 1,251 funds tracked by Wall St. Rank hold EXC as of Q4 2025.

  • Rise Advisors reported no remaining Exelon position as of Q4 2025 after selling out during the quarter.
  • Rise Advisors sold 556 Exelon shares in Q4 2025, an estimated $25K.
  • Rise Advisors first reported a position in Exelon in Q1 2024 and held it in 7 quarters.
  • Rise Advisors's Exelon position peaked at $25.8K in Q3 2024.
  • 1,251 funds tracked by Wall St. Rank held Exelon as of Q4 2025.

Based on Rise Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.